LONDON--(BUSINESS WIRE)--Lightlake Therapeutics Inc. (OTCBB: LLTP) (the “Company” or “Lightlake”), an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today that it has launched its new corporate website, http://lightlaketherapeutics.com, and will be conducting a conference call followed by a Q & A session on Tuesday, November 29, 2011 at 5:00 PM EST to update shareholders and other interested parties on the Company’s current endeavors.
